
STARTS NOW Rebels Edge 1pm $RVMD $GS $FAST $BBY 🏈 NAJARIAN SPORTS 🏴☠️ with @petenajarian GOLF: Masters, Mcilroy was on fire Rory 2nd round was epic, he lead after every round NFL: Draft in 10 days 3 players that are moving up: Freeling, Thineman, Gentry #ITSNOTANOPTION 📙 https://t.co/UqitZZUz62
Revolution Medicines plummets on report Merck walks from acquisition talks
Revolution Medicines declines to comment on M&A speculation at conference
Merck in talks to acquire Revolution Medicines for about $30B - WSJ
Revolution Medicines soars on report Merck in talks to buy
34.87BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US76155X1000
CUSIP
76155X100
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
11.11
Dividend Share
-
Dividend Yield
-
Earnings Share
-9.13
Wall Street Target Price
274.68
EPS Estimate Current Year
-8.18
EPS Estimate Next Year
-2.72
EPS Estimate Current Quarter
-2.3813
EPS Estimate Next Quarter
-1.9767
Most Recent Quarter
-
Revenue TTM
197,559,008
Gross Profit TTM
-1,253,687,040
EBITDA
-1,675,138,944
Profit Margin
0.00%
Return On Assets TTM
-32.13%
Return On Equity TTM
-93.56%
Revenue Per Share TTM
0.965
Qtly Revenue Growth YOY
-95.20%
Diluted Eps TTM
-9.13
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
176.4856
Price Book MRQ
14.5185
Enterprise Value Revenue
161
Enterprise Value EBITDA
-9
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%